BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35053718)

  • 21. Assessing the health of the general population in England: how do the three- and five-level versions of EQ-5D compare?
    Feng Y; Devlin N; Herdman M
    Health Qual Life Outcomes; 2015 Oct; 13():171. PubMed ID: 26489956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validity and feasibility of the self-report EQ-5D-Y as a generic Health-Related Quality of Life outcome measure in children and adolescents with Juvenile Idiopathic Arthritis in Western Cape, South Africa.
    Scott D; Scott C; Jelsma J; Abraham D; Verstraete J
    S Afr J Physiother; 2019; 75(1):1335. PubMed ID: 31392295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy.
    Bulamu NB; Vissapragada R; Chen G; Ratcliffe J; Mudge LA; Smithers BM; Isenring EA; Smith L; Jamieson GG; Watson DI;
    Health Qual Life Outcomes; 2021 Oct; 19(1):233. PubMed ID: 34600554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys.
    Martí-Pastor M; Pont A; Ávila M; Garin O; Vilagut G; Forero CG; Pardo Y; Tresserras R; Medina-Bustos A; Garcia-Codina O; Cabasés J; Rajmil L; Alonso J; Ferrer M
    Popul Health Metr; 2018 Aug; 16(1):14. PubMed ID: 30115092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reliability and validity of a self-administration version of DEMQOL-Proxy.
    Hendriks AAJ; Smith SC; Chrysanthaki T; Black N
    Int J Geriatr Psychiatry; 2017 Jul; 32(7):734-741. PubMed ID: 27272129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Responsiveness of EQ-5D Youth version 5-level (EQ-5D-5L-Y) and 3-level (EQ-5D-3L-Y) in Patients With Idiopathic Scoliosis.
    Wong CKH; Cheung PWH; Luo N; Lin J; Cheung JPY
    Spine (Phila Pa 1976); 2019 Nov; 44(21):1507-1514. PubMed ID: 31634302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of the German version of EQ-5D-Y-5L to measure health-related quality of life in children and adolescents: Identification of response labels and pilot testing].
    Kreimeier S; Greiner W
    Z Evid Fortbild Qual Gesundhwes; 2019 Aug; 144-145():24-34. PubMed ID: 31378708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
    Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M
    Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the EQ-5D-3L and 5L versions in low back pain patients.
    Garratt AM; Furunes H; Hellum C; Solberg T; Brox JI; Storheim K; Johnsen LG
    Health Qual Life Outcomes; 2021 May; 19(1):155. PubMed ID: 34049574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychometric properties of the Japanese version of the EQ-5D-Y by self-report and proxy-report: reliability and construct validity.
    Shiroiwa T; Fukuda T; Shimozuma K
    Qual Life Res; 2019 Nov; 28(11):3093-3105. PubMed ID: 31243620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases.
    Scalone L; Ciampichini R; Fagiuoli S; Gardini I; Fusco F; Gaeta L; Del Prete A; Cesana G; Mantovani LG
    Qual Life Res; 2013 Sep; 22(7):1707-16. PubMed ID: 23192232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
    Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
    Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The EQ-5D-5L Improves on the EQ-5D-3L for Health-related Quality-of-life Assessment in Patients Undergoing Total Hip Arthroplasty.
    Greene ME; Rader KA; Garellick G; Malchau H; Freiberg AA; Rolfson O
    Clin Orthop Relat Res; 2015 Nov; 473(11):3383-90. PubMed ID: 25488404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient-caregiver agreement and test-retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies.
    Zhou W; Shen A; Yang Z; Wang P; Wu B; Herdman M; Luo N
    Eur J Health Econ; 2021 Sep; 22(7):1103-1113. PubMed ID: 33950465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients.
    Pickard AS; De Leon MC; Kohlmann T; Cella D; Rosenbloom S
    Med Care; 2007 Mar; 45(3):259-63. PubMed ID: 17304084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychometric properties of the EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in caregivers of autistic children.
    Khanna R; Jariwala K; Bentley JP
    Qual Life Res; 2013 Dec; 22(10):2909-20. PubMed ID: 23615959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey.
    Jankowska A; Młyńczak K; Golicki D
    Health Qual Life Outcomes; 2021 May; 19(1):138. PubMed ID: 33952271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany.
    Eidt-Koch D; Mittendorf T; Greiner W
    BMC Pediatr; 2009 Aug; 9():55. PubMed ID: 19715563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the CHU-9D and the EQ-5D-Y instruments in children and young people with cerebral palsy: a cross-sectional study.
    Ryan JM; McKay E; Anokye N; Noorkoiv M; Theis N; Lavelle G
    BMJ Open; 2020 Sep; 10(9):e037089. PubMed ID: 32912983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis.
    Yfantopoulos J; Chantzaras A; Kontodimas S
    Arch Dermatol Res; 2017 Jul; 309(5):357-370. PubMed ID: 28528371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.